Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03043313
Title Tucatinib Plus Trastuzumab in Patients With HER2+ Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Seattle Genetics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | BEL

Additional content available in CKB BOOST